Tundi, Abdul .
HRN: 11-19-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
METRONIDAZOLE 500MG (TAB)
03/03/2025
03/10/2025
PO
500mg
TID
PUD Sec To H Pylori
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes